亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Comparison of Two Presbyopia-Correcting Trifocal Intraocular Lenses: A Prospective Study

老花眼 人工晶状体 验光服务 眼科 医学 人工晶状体
作者
Hasan Alı Bayhan,Yelda Yıldız Taşçı,Seray Aslan Bayhan,Tamer Takmaz,İzzet Can
出处
期刊:Türk Oftalmoloji Dergisi [Galenos Yayinevi]
卷期号:54 (2): 63-68 被引量:1
标识
DOI:10.4274/tjo.galenos.2024.27657
摘要

Objectives: To evaluate the clinical results of a new trifocal intraocular lens (IOL) with sinusoidal design by comparing with a traditional trifocal IOL.Materials and Methods: A total of 79 patients undergoing uneventful microincisional cataract surgery with bilateral implantation of one of two types of trifocal IOLs, the Acriva Trinova IOL (VSY) or Acrysof IQ PanOptix IOL (Alcon), were enrolled in this prospective study.Visual and refractive outcomes, contrast sensitivity (CS), and defocus curve were assessed at 3 months after surgery.Patient satisfaction and incidence of photic phenomena were also evaluated. Results:The number of patients/eyes were 48/96 in the Trinova group and 31/62 in the PanOptix group.There were no significant differences between the groups for monocular and binocular corrected/uncorrected distance or intermediate (at 60 cm) and near visual acuities (VA) postoperatively.The Trinova group had statistically significantly better intermediate VA at 80 cm than the PanOptix group (p<0.05).The CS results of both groups were within the normal limits.In the binocular defocus curve of both IOLs, we observed a peak of good VA at 0.0 diopters defocus and a useful wide range for intermediate distances.The incidence of photic phenomena in the Trinova group was lower at postoperative 1 month (p<0.05)but this difference disappeared at 3 months.A total of 47 patients (97.9%) in the Trinova group and 30 patients (96.7%) in the PanOptix group stated that they would recommend the same IOL.Conclusion: Both trifocal IOLs provide good visual quality outcomes and patient satisfaction.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.3应助花花懿懿采纳,获得10
刚刚
3秒前
big发布了新的文献求助10
3秒前
小骁同学完成签到,获得积分10
6秒前
asia完成签到 ,获得积分10
7秒前
susan发布了新的文献求助10
8秒前
田様应助小骁同学采纳,获得10
9秒前
Geodada完成签到,获得积分10
17秒前
雨寒完成签到 ,获得积分10
19秒前
28秒前
凉宫八月完成签到,获得积分10
28秒前
诚心爆米花完成签到 ,获得积分10
30秒前
从容水蓝应助big采纳,获得10
38秒前
菠萝嘉嘉关注了科研通微信公众号
45秒前
45秒前
45秒前
48秒前
LLL发布了新的文献求助10
50秒前
李宏飞发布了新的文献求助10
51秒前
53秒前
SciGPT应助LLL采纳,获得10
56秒前
汉堡包应助QDK采纳,获得10
58秒前
59秒前
1分钟前
1分钟前
jinmuna完成签到,获得积分10
1分钟前
橘x应助thought采纳,获得30
1分钟前
1分钟前
菠萝嘉嘉发布了新的文献求助10
1分钟前
星空发布了新的文献求助10
1分钟前
LLL完成签到,获得积分10
1分钟前
QDK完成签到,获得积分10
1分钟前
丘比特应助黑夜不黑夜呀采纳,获得10
1分钟前
单纯一笑完成签到,获得积分10
1分钟前
1分钟前
1分钟前
FashionBoy应助科研通管家采纳,获得10
1分钟前
小田完成签到,获得积分10
1分钟前
QDK发布了新的文献求助10
1分钟前
小田发布了新的文献求助10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6012362
求助须知:如何正确求助?哪些是违规求助? 7568015
关于积分的说明 16138831
捐赠科研通 5159306
什么是DOI,文献DOI怎么找? 2763030
邀请新用户注册赠送积分活动 1742206
关于科研通互助平台的介绍 1633917